my country's biopharmaceutical equipment market is broad
The rapid rise of my country’s biopharmaceutical market has increased the demand for biopharmaceutical equipment. Biomedicine is one of the important pillar industries of the modern pharmaceutical industry. Now, with the introduction of a series of national policies, domestic pharmaceutical companies are shifting from "generic drug strategy" to " In the transformation of "innovative drug strategy", some pharmaceutical companies focusing on the research and development of new drugs have gradually emerged in my country, and bull stocks in the biomedical field have continued to appear.
According to the report released at the 2019 China Biotechnology Innovation Conference held recently, the market size of my country's biomedical industry in 2018 has exceeded 350 billion yuan, and 9 independently developed Class 1 new drugs have been approved for listing... These data fully demonstrate my country The level of biomedicine is constantly improving. According to the industry, with the rapid rise of my country's biomedical industry, the demand for pharmaceutical equipment is also expanding.

The rapid rise of my country's biopharmaceutical market has increased the demand for biopharmaceutical equipment

Biomedicine is one of the important pillar industries of the modern pharmaceutical industry. Today, with the introduction of a series of national policies, domestic pharmaceutical companies are transforming from "generic drug strategy" to "innovative drug strategy". Pharmaceutical companies, and bull stocks in the biomedical field are constantly appearing.

As the country pays more and more attention to the research and development of innovative drugs, the market's demand for biomedicine will continue to grow. In the future, the biomedical field may also produce more big bull stocks. Nowadays, the biomedicine industry has risen to a national strategic emerging industry, and its market size is continuing to grow at a relatively rapid rate. Data shows that the size of my country’s biomedicine market has an average annual compound growth rate of 21.9% from 2014 to 2018. Far higher than the growth rate of the pharmaceutical market. It is predicted that by 2021, the market size of my country's biomedical industry will reach 326.9 billion yuan.
Biopharmaceutical equipment
The rapid development of my country's biomedical industry is a great news for patients, and at the same time, it is also a great news for the upstream pharmaceutical equipment industry. According to the industry, with the vigorous development of the biopharmaceutical industry, the market demand for biopharmaceutical equipment in my country will also further expand, and the biopharmaceutical equipment industry will usher in a broad market space.

The author has learned that in recent years, with the continuous increase in market demand, my country's pharmaceutical equipment companies have also continued to make efforts, and biopharmaceutical equipment products and technologies have also emerged in endlessly. For example, Tianshui Huayuan produced biological microwave extraction equipment under this opportunity; another drug The bio-extraction equipment produced by the mechanical enterprises in response to market demand has made major improvements in terms of energy saving and efficiency. "Through fully closed loop extraction and concentration, the biological extraction equipment can save energy by 0.3-0.5 times; in addition, the equipment can reduce solvents by 0.5-1 times according to different drugs, increase the feeding volume by 30%-60%, and increase the cream yield by 10% Above." The person in charge of the company introduced.

The market for biopharmaceutical equipment is vast, but pharmaceutical companies still rely on imported equipment

The rapid development of the biopharmaceutical industry has made my country's biopharmaceutical equipment industry usher in a huge market opportunity, and some new technologies and equipment have begun to emerge. The birth of new biopharmaceutical equipment products and technologies is of great significance to the development and quality improvement of biopharmaceuticals in my country. However, it is worth mentioning that, from the current point of view, my country’s biopharmaceutical equipment is lacking in the mid-to-high-end market, the industry’s overall innovation capability is still weak, and the product quality is also uneven. Pharmaceutical companies have relatively high trust in domestic biopharmaceutical equipment. Low, many companies are more dependent on imported equipment. For example, the person in charge of a domestic biopharmaceutical company said in an interview with the media that 95% of the company's biopharmaceutical equipment is imported.

The above-mentioned people further stated that the production process of biomedicine is more complicated than traditional Chinese medicine and chemical medicine. "Traditional Chinese medicine is processed, chemical medicine is synthesized by small molecules, and biological medicine is grown from living cells." In the production process of biomedicine, there can be no more than 20 dust particles per cubic meter (air). On the one hand, The requirements for cleanliness are higher, and on the other hand, the requirements for aseptic production are also higher.

It is understood that biopharmaceuticals have very strict requirements on the pharmaceutical environment, and they have higher requirements for the sterile and pollution-free conditions of pharmaceutical equipment. Therefore, they also put forward higher requirements on the structural parameters, process parameters, and control methods of the equipment. In these aspects, domestic equipment still has a large gap compared with foreign advanced equipment.

For example, the production equipment used in the traditional biopharmaceutical production process is made of stainless steel, which not only makes the production and installation of the equipment take a long time, but also brings the heavy work of cleaning, sterilization and disinfection for pharmaceutical companies. The key is that there is also cross-contamination. risks of. In response to this, a foreign company has launched a disposable technology, which has the ability to provide users in the biopharmaceutical industry with the technology and required equipment for a complete production process.

In recent years, with the rapid rise of the domestic biopharmaceutical industry, many multinational pharmaceutical equipment companies have successively deployed my country's market, and have been trusted by domestic companies by virtue of their technological advantages. Facing the market environment of "wolves before and tigers", analysts said that my country's biopharmaceutical equipment companies should seize market opportunities provided by national policy support, continue to carry out technological innovation, stabilize product performance, and improve product technology and quality. Win the market with cost-effective products.